Agilent Technologies Inc. logo

Agilent Technologies Inc.

A | NYSE
Chart Builder DCF Calculator
$174.87
-$6.28 (-3.47%)
At close: Oct 30, 2026, 4:00 PM ET
$175.30
+$0.43 (+0.25%)
Pre-market: Nov 2, 2026, 7:29 AM ET

Company Profile

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Key Executives

Name Position
Padraig McDonnell Chief Executive Officer, President & Director
Adam S. Elinoff Senior Vice President, Chief Financial Officer & Principal Financial Officer
August Specht Senior Vice President & Chief Technology Officer
Michael Buckner Senior Vice President, Chief Legal Officer, & Secretary
Angelica Riemann Senior VP & President of Agilent CrossLab Group
Frederick Schwarz Senior VP, Chief Strategy & Corporate Development Officer
Rodney Gonsalves Vice President of Finance
Simon May Senior VP and President of Life Sciences & Diagnostics Markets Group
Tejas Rajeev Savant Vice President of Investor Relations
Tim Downs VP & Chief Accounting Officer

Latest SEC Filings

Date Type Title
Sep 23, 2026 EFFECT Filing
Sep 23, 2026 424B3 Filing
Sep 10, 2026 4 Filing
Sep 10, 2026 3 Filing
Sep 09, 2026 4 Filing
Sep 08, 2026 8-K Current Report
Sep 01, 2026 S-4 Filing
Sep 01, 2026 S-3ASR Automatic shelf registration statement of securiti...
Sep 01, 2026 10-Q Quarterly Report
Aug 26, 2026 8-K Current Report
View All SEC Filings ➞
Agilent Technologies Inc.
Agilent Technologies Inc. logo
Country United States
IPO Date Nov 18, 1999
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 18,200
CEO Padraig McDonnell

Contact Details

5301 Stevens Creek Boulevard Santa Clara, California 95051 United States

Stock Details

Ticker Symbol A
Exchange NYSE
Fiscal Year November - October
Reporting Currency USD
CIK Code 0001090872
CUSIP Number 00846U101
ISIN Number US00846U1016
SIC Code 3826

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.